ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease

Novak, P (author)

Kovacech, B (author)

Katina, S (author)

show more...

Schmidt, R (author)

Scheltens, P (author)

Kontsekova, E (author)

Ropele, S (author)

Fialova, L (author)

Kramberger, M (author)

Paulenka-Ivanovova, N (author)

Smisek, M (author)

Hanes, J (author)

Stevens, E (author)

Kovac, A (author)

Sutovsky, S (author)

Parrak, V (author)

Koson, P (author)

Prcina, M (author)

Galba, J (author)

Cente, M (author)

Hromadka, T (author)

Filipcik, P (author)

Piestansky, J (author)

Samcova, M (author)

Prenn-Gologranc, C (author)

Sivak, R (author)

Froelich, L (author)

Fresser, M (author)

Rakusa, M (author)

Harrison, J (author)

Hort, J (author)

Otto, M (author)

Tosun, D (author)

Ondrus, M (author)

Winblad, B (author)

Karolinska Institutet

Novak, M (author)

Zilka, N (author)

show less...

 (creator_code:org_t)

2021-06-14

2021

English.

In: Nature aging. - : Springer Science and Business Media LLC. - 2662-8465. ; 1:6, s. 521-

Related links:

https://doi.org/10.1...

show more...

http://kipublication...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)